tert-Butyl 3-(1-aminoethyl)-1H-indole-1-carboxylate

Catalog No.: 
ACRGXZ397
CAS No.: 
317830-77-6
Molecular Formula: 
C15H20N2O2
Molecular Weight: 
260.34
tert-Butyl 3-(1-aminoethyl)-1H-indole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%
1g97%
5g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(1-aminoethyl)-1H-indole-1-carboxylate
IUPAC Nametert-butyl 3-(1-aminoethyl)-1H-indole-1-carboxylate
Molecular FormulaC15H20N2O2
Molecular Weight260.34
SMILESO=C(N1C=C(C(N)C)C2=C1C=CC=C2)OC(C)(C)C
InChI KeyXEQUWHVSDLOFGR-UHFFFAOYSA-N
Synonym3-(1-AMINO-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;tert-butyl 3-(1-aminoethyl)-1H-indole-1-carboxylate;3-(1-aminoethyl)-1-indolecarboxylic acid tert-butyl ester;1H-Indole-1-carboxylic acid, 3-(1-aminoethyl)-, 1,1-dimethylethyl ester
CAS No.317830-77-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACRGXZ397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMNUE538 route compound structure diagram
    ACMNUE538124688-00-2In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACRGXZ397 route product structure diagram
    ACRGXZ397317830-77-6
Inquiry

2. ACRGXZ397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRGXZ397 route product structure diagram
    ACRGXZ397317830-77-6
Inquiry

3. ACRGXZ397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRGXZ397 route product structure diagram
    ACRGXZ397317830-77-6
Inquiry

Comments (0)